Birte Petersen Jakobsen

Birte Petersen Jakobsen

Auto-generated profile, based on publicly available information

Birte Petersen Jakobsen

Consultant MD, MedDevHealth, Geelsvej, 15 2840 Holte, Denmark

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2019 in Advances in Urology
Verified
Journal Article
Open access
MKMichael Joseph Kennelly
Michael Joseph Kennelly
NTNikesh Thiruchelvam
Nikesh Thiruchelvam
MAMárcio Augusto Averbeck
Márcio Augusto Averbeck
CKCharalampos Konstatinidis
Charalampos Konstatinidis
ECEmmanuel Chartier-Kastler
Emmanuel Chartier-Kastler
BJBirte Petersen Jakobsen
Birte Petersen Jakobsen
A risk factor model for urinary tract infections in patients with adult neurogenic lower urinary tract dysfunction performing clean intermittent catheterisation was developed; it consists of four domains, namely, (1) general (systemic) conditions in the patient, (2) individual urinary tract conditions in the patient, (3) routine aspects related to the patient, and (4) factors related to intermittent catheters per se. The conceptual model primarily concerns patients with spinal cord injury, spina bifida, multiple sclerosis, or cauda equina where intermittent catheterisation is a normal part of the bladder management. On basis of several literature searches and author consensus in case of lacking evidence, the model intends to provide an overview of the risk factors involved in urinary tract infections, with specific emphasis to describe those that in daily practice can be handled and modified by the clinician and so come to the benefit of the individual catheter user in terms of fewer urinary tract infections.

10 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AFAkira Furuta
Akira Furuta
YSYasuyuki Suzuki
Yasuyuki Suzuki
RTRyosuke Takahashi
Ryosuke Takahashi
BJBirte Petersen Jakobsen
Birte Petersen Jakobsen
TKTakahiro Kimura
Takahiro Kimura
NYNaoki Yoshimura
Naoki Yoshimura
Recent studies using 16S rRNA-based microbiota profiling have demonstrated dysbiosis of gut microbiota in constipated patients. The aim of this study was to investigate the changes in gut microbiota after transanal irrigation (TAI) in patients with spina bifida (SB). A questionnaire on neurogenic bowel disfunction (NBD), Bristol scale, and gut microbiota using 16S rRNA sequencing were completed in 16 SB patients and 10 healthy controls aged 6–17 years. Then, 11 of 16 SB patients with moderate to severe NBD scores received TAI for 3 months. Changes in urine cultures were also examined before and after the TAI treatments. In addition, correlation of gut microbiota and Bristol scale was analyzed. Significantly decreased abundance in Faecalibacterium, Blautia and Roseburia, and significantly increased abundance in Bacteroides and Roseburia were observed in the SB patients compared with controls and after TAI, respectively. The abundance of Roseburia was significantly correlated positively with Bristol scale. Urinary tract infection tended to decrease from 82% to 55% after TAI (p = 0.082) despite persistent fecal incontinence. Butyrate-producing bacteria such as Roseburia play a regulatory role in the intestinal motility and host immune system, suggesting the effects of TAI on gut microbiota.